The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Combriato, G.
Right arrow Articles by Klobeck, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Combriato, G.
Right arrow Articles by Klobeck, H.-G.
The Journal of Immunology, 2002, 168: 1259-1266.
Copyright © 2002 by The American Association of Immunologists

Regulation of Human Ig{lambda} Light Chain Gene Expression by NF-{kappa}B1

Gabriele Combriato and H.-Gustav Klobeck2

Adolf Butenandt Institut Molekularbiologie, Munich, Germany

The human Ig{lambda} enhancer consists of three separated sequence elements that we identified previously by mapping DNase I-hypersensitive regions (HSS) downstream of the C region of the Ig{lambda} L chain genes (HSS-1, HSS-2, and HSS-3). It has been shown by several laboratories that expression of the H chain genes as well as the {kappa} genes, but not the {lambda} genes, is dependent on constitutive NF-{kappa}B proteins present in the nucleus. In this study we show by band-shift experiments, in vivo footprinting, and transient transfection assays that all three hypersensitive sites of the human Ig{lambda} enhancer contain functional NF-{kappa}B sites that act synergistically on expression. We further show that the chicken {lambda} enhancer also contains a functional NF-{kappa}B site but the mouse {lambda} enhancer contains a mutated, nonfunctional NF-{kappa}B site that is responsible for its low enhancer activity. It is possible that the inactivating mutation in the mouse Ig{lambda} enhancer was compensated for by an expansion of the Ig{kappa} L chain locus, followed by a contraction of the Ig{lambda} locus in this species.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. M. Souto-Carneiro, R. Fritsch, N. Sepulveda, M. J. Lagareiro, N. Morgado, N. S. Longo, and P. E. Lipsky
The NF-{kappa}B Canonical Pathway Is Involved in the Control of the Exonucleolytic Processing of Coding Ends during V(D)J Recombination
J. Immunol., January 15, 2008; 180(2): 1040 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Martone, G. Euskirchen, P. Bertone, S. Hartman, T. E. Royce, N. M. Luscombe, J. L. Rinn, F. K. Nelson, P. Miller, M. Gerstein, et al.
Distribution of NF-{kappa}B-binding sites across human chromosome 22
PNAS, October 14, 2003; 100(21): 12247 - 12252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.